DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award

Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, the enterprise leading orchestration platform for precision health, today announced it has received the PharmaTech Innovation Award as part of the 10^th annual MedTech Breakthrough Awards. This accolade honors DNAnexus as a catalyst in precision medicine, recognizing its AI-enabled platform for its ability to transform raw multimodal data into scientific discovery and underscoring its transformative impact on the global biopharma ecosystem.

The annual MedTech Breakthrough Awards program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, platforms and products in the global digital health, fitness and medical technology industries. Their rigorous process reviewed, scored, and analyzed over 5,000 nominations to ensure each award is granted based on excellence and paradigm-shifting advancements.

"Receiving the PharmaTech Innovation Award is a testament to our commitment to transforming the omics data landscape,” said Todd Oakland, Senior Vice President and General Manager of Biopharma and Diagnostics at DNAnexus. “By streamlining the path from complex multimodal data to actionable insights, we are empowering our partners to accelerate the delivery of life-changing targeted therapeutics."

The AI-Powered Foundation for Pharma Innovation

At the heart of the DNAnexus enterprise orchestration platform is a global network of scientists and the world's largest repository of genomic and omics data. This massive foundation serves as the backbone bridging the gap between raw multimodal inputs and AI-driven breakthroughs, empowering users to transform fragmented multiomic datasets into scalable AI workflows.

For pharma teams, this translates into the ability to train and deploy advanced machine learning models to identify novel targets, validate biomarkers, and optimize clinical trial designs—all within a governed, regulatory-ready framework. Ultimately, these capabilities enable pharma organizations to operationalize AI-driven insights that advance the biopharma value chain and expedite the delivery of critical therapies to market.

To view the full list of winners from the 2026 MedTech Breakthrough Awards, click here. For more information about DNAnexus and its award-winning platform, visit https://www.dnanexus.com/.

About DNAnexus

Founded in 2009, DNAnexus is the ​enterprise orchestration platform for precision health. A pioneer in cloud-based omics and purpose-built bioinformatics for life sciences, DNAnexus helps customers ​contextualize, ​orchestrate, and ​f​ederate ​multiomic and real-world data to derive actionable insights and accelerate ​the journey from sequence to scientific breakthrough. DNAnexus accomplishes this through its​​ compliance-first, AI-enabled platform, equipped to handle extreme scale and complex data processing for genomics, multiomics, and beyond. For more information, visit www.dnanexus.com.